Starting treatment: latest news

Starting treatment resources

Starting treatment features

Starting treatment in your own words

Starting treatment news from aidsmap

More news

Starting treatment news selected from other sources

  • Inflammation Persists Despite Very Early HIV Treatment

    Biomarkers of inflammation increase during acute HIV infection and remain elevated despite early suppressive antiretroviral therapy, according to a study presented at CROI 2015, in Seattle, Washington.

    27 February 2015 | The Body Pro
  • HIV Positive Guys Need To Consider Going On Meds Earlier — ACON

    MORE HIV-positive men need to think about starting treatment straight after diagnosis if ambitious targets to end HIV transmission by 2020 are to be met, the head of New South Wales based LGBTI health body ACON has said. The comments come as the organisation launches a major new sexual health campaign that also aims to clear up confusion surrounding one of the newest buzzwords in the HIV lexicon: "undetectable".

    23 February 2015 | Star Observer
  • The Search for a Permanent Alternative to HIV Drugs

    Researchers Carefully Tailor a Study to Find Patients to Test Going Off Antiretroviral Medication

    16 February 2015 | Wall Street Journal
  • HIV Organizations Urge Continuation of D:A:D Study

    D:A:D follows 50,000 HIV-positive people, looking at drug safety and side effects over time. Results from D:A:D have changed HIV treatment guidelines, and how HIV-positive people are treated by their health care providers. We urge pharmaceutical companies to continue funding this vital study.

    11 February 2015 | Treatment Action Group
  • Dolutegravir and Truimeq approved in England: London guidelines updated

    On 14 January 2015, NHS England published the long awaited policy on dolutegravir and the fixed dose combination (FDC) of dolutegravir/abacavir/3TC (Triumeq). The London prescribing guidelines for first-line therapy have also been updated to include dolutegravir and Triumeq.

    14 January 2015 | HIV i-Base
  • Study uncovers new ground about when to start HIV therapy

    A major question that has recurred since the availability of potent combination anti-HIV therapy (commonly called ART or HAART) is when this therapy should be initiated to ensure the optimal health of HIV-positive people. New research has revealed that early therapy may be highly beneficial.

    13 January 2015 | CATIE
  • Dolutegravir/abacavir/lamivudine: considerable added benefit for treatment-naive adults with HIV

    Since September 2014, the fixed-dose combination of dolutegravir/abacavir/lamivudine (trade name Triumeq) has been approved for human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age. The Institute for Quality and Efficiency in Health Care (IQWiG), which had already assessed a dossier on dolutegravir in spring 2014, now examined in another dossier assessment whether the drug combination also offers an added benefit over the appropriate comparator therapy.

    12 January 2015 | The Institute for Quality and Efficiency in Health Care
  • First Year After HIV Infection Is Key Window for Treatment Start

    Waiting to start HIV treatment until 12 months after the estimated date of seroconversion decreases the likelihood of restoring the immune system.

    07 January 2015 | AIDSMeds
  • How San Francisco Is Getting to Zero On HIV

    San Francisco is already making progress when it comes to HIV prevention, treatment and retention. In 2006, San Francisco had 517 new HIV cases; by 2013, that number dropped to 359, a 30 percent decrease. The number of deaths almost halved between 2006 and 2013, going from 327 to 182. Additionally, compared to the United States, San Francisco is faring better in multiple aspects of the HIV care continuum: in 2012, 82 percent of HIV positive individuals in the U.S. were aware of their status; in San Francisco, that number was 94 percent.

    11 December 2014 | Huffington Post
  • Starting HIV Meds Within a Year of Infection Helps Restore CD4s

    Beginning treatment for HIV within a year of infection improves the likelihood of returning an individual’s CD4 count to a normal level.

    03 December 2014 | AIDSMeds
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.